Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10100501 | The Journal of Sexual Medicine | 2005 | 8 Pages |
Abstract
Given the high cost and inherent risk of clinical studies, continued development efforts toward FSD therapies are unlikely to proceed in the absence of significant changes in regulatory guidance that reflect the current understanding of FSD and incorporate validated assessment tools. Althof SE, Dean J, Derogatis LR, Rosen RC, and Sisson M. Current perspectives on the clinical assessment and diagnosis of female sexual dysfunction and clinical studies of potential therapies: a statement of concern. J Sex Med 2005;2(suppl 3):146-153.
Related Topics
Health Sciences
Medicine and Dentistry
Urology
Authors
Stanley E. PhD, John MD, Leonard R. PhD, Raymond C. PhD, Melanie AuD,